Tocotrienol alleviates inflammation and oxidative stress in a rat model of spinal cord injury via suppression of transforming growth factor-β

  • Authors:
    • Chuanhui Xun
    • Mardan Mamat
    • Hailong Guo
    • Pulat Mamati
    • Jun Sheng
    • Jian Zhang
    • Tao Xu
    • Weidong Liang
    • Rui Cao
    • Weibin Sheng
  • View Affiliations

  • Published online on: May 23, 2017     https://doi.org/10.3892/etm.2017.4505
  • Pages: 431-438
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

In recent years accumulating evidence has indicated that tocotrienol exhibits an oxidation resistance function, decreased cholesterol function, inhibits cancer function and has unique physiological functions, including anti-inflammatory, anti‑apoptotic and anti‑oxidative properties. The present study investigated the effect of tocotrienols on spinal cord injury (SCI) by evaluating oxidative stress, inflammation and inducible nitric oxide synthase (iNOS) in rats. A rat model of SCI was induced by operation. SCI rats were treated with 120 mg/kg/day tocotrienol once a day for eight consecutive weeks. Functional recovery following SCI was measured by using the Basso Beattie Bresnahan (BBB) locomotor rating scale. Then the volume of spinal cord contusions was measured following induction of SCI in the rats. In SCI rats, serum malondialdehyde, superoxide dismutase, catalase, glutathione peroxidase, nuclear factor‑κB p65 unit, tumor necrosis factor‑α, interleukin (IL)‑1β and IL‑6 levels were analyzed using respective commercial immunoassay kits. Firstly, iNOS, transforming growth factor (TGF)‑β, collagen type IV and fibronectin protein expression levels, in addition to iNOS activity and plasma nitric oxide (NO) production in SCI rats was analyzed using western blot analysis, commercial kits and Griess reagent, respectively. Tocotrienol treatment elevated BBB scores and contused volume in the SCI rats. Tocotrienol protected against SCI with reduced oxidative stress and inflammation, and inhibited iNOS protein expression iNOS activity and plasma NO production in rats. In addition, treatment with tocotrienols suppressed TGF‑β, collagen type IV and fibronectin protein expression levels in SCI rats. These results suggest that tocotrienols protect SCI, and suppress oxidative stress, inflammation and iNOS in this model of SCI through TGF‑β, collagen type IV and fibronectin signaling pathways.

References

1 

Rosado IR, Lavor MS, Alves EG, Fukushima FB, Oliveira KM, Silva CM, Caldeira FM, Costa PM and Melo EG: Effects of methylprednisolone, dantrolene, and their combination on experimental spinal cord injury. Int J Clin Exp Pathol. 7:4617–4626. 2014.PubMed/NCBI

2 

Song Q, Xu R, Zhang Q, Ma M and Zhao X: Therapeutic effect of transplanting bone mesenchymal stem cells on the hind limbs' motor function of rats with acute spinal cord injury. Int J Clin Exp Med. 7:262–267. 2014.PubMed/NCBI

3 

Liu C, Huang Z, Jiang H and Shi F: The sirtuin 3 expression profile is associated with pathological and clinical outcomes in colon cancer patients. Biomed Res Int. 2014:8712632014.PubMed/NCBI

4 

Guo J, Li Y, He Z, Zhang B, Li Y, Hu J, Han M, Xu Y, Li Y, Gu J, et al: Targeting endothelin receptors A and B attenuates the inflammatory response and improves locomotor function following spinal cord injury in mice. Int J Mol Med. 34:74–82. 2014.PubMed/NCBI

5 

Grasso G, Meli F, Graziano F, Stagno V, Imbrucè P, Florena AM, Maugeri R and Iacopino DG: Chronic inflammation causing spinal cord compression in human immunodeficiency virus infection. Med Sci Monit. 14:CS134–CS137. 2008.PubMed/NCBI

6 

Ji H, Tang H, Lin H, Mao J, Gao L, Liu J and Wu T: Rho/Rock cross-talks with transforming growth factor-β/Smad pathway participates in lung fibroblast-myofibroblast differentiation. Biomed Rep. 2:787–792. 2014.PubMed/NCBI

7 

Yu Z, Yu P, Chen H and Geller HM: Targeted inhibition of KCa3.1 attenuates TGF-β-induced reactive astrogliosis through the Smad2/3 signaling pathway. J Neurochem. 130:41–49. 2014. View Article : Google Scholar : PubMed/NCBI

8 

Banh A, Deschamps PA, Gauldie J, Overbeek PA, Sivak JG and West-Mays JA: Lens-specific expression of TGF-beta induces anterior subcapsular cataract formation in the absence of Smad3. Invest Ophthalmol Vis Sci. 47:3450–3460. 2006. View Article : Google Scholar : PubMed/NCBI

9 

Loganathan R, Selvaduray KR, Nesaretnam K and Radhakrishnan AK: Tocotrienols promote apoptosis in human breast cancer cells by inducing poly(ADP-ribose) polymerase cleavage and inhibiting nuclear factor kappa-B activity. Cell Prolif. 46:203–213. 2013. View Article : Google Scholar : PubMed/NCBI

10 

Das S, Mukherjee S, Lekli I, Gurusamy N, Bardhan J, Raychoudhury U, Chakravarty R, Banerji S, Knowlton AA and Das DK: Tocotrienols confer resistance to ischemia in hypercholesterolemic hearts: Insight with genomics. Mol Cell Biochem. 360:35–45. 2012. View Article : Google Scholar : PubMed/NCBI

11 

Zarogoulidis P, Cheva A, Zarampouka K, Huang H, Li C, Huang Y, Katsikogiannis N and Zarogoulidis K: Tocopherols and tocotrienols as anticancer treatment for lung cancer: Future nutrition. J Thorac Dis. 5:349–352. 2013.PubMed/NCBI

12 

Tanito M, Itoh N, Yoshida Y, Hayakawa M, Ohira A and Niki E: Distribution of tocopherols and tocotrienols to rat ocular tissues after topical ophthalmic administration. Lipids. 39:469–474. 2004. View Article : Google Scholar : PubMed/NCBI

13 

Sylvester PW, Akl MR, Malaviya A, Parajuli P, Ananthula S, Tiwari RV and Ayoub NM: Potential role of tocotrienols in the treatment and prevention of breast cancer. Biofactors. 40:49–58. 2014. View Article : Google Scholar : PubMed/NCBI

14 

Zhang X, Chen C, Ma S, Wang Y, Zhang X and Su X: Inhibition of monocyte chemoattractant peptide-1 decreases secondary spinal cord injury. Mol Med Rep. 11:4262–4266. 2015.PubMed/NCBI

15 

Wong WY, Poudyal H, Ward LC and Brown L: Tocotrienols reverse cardiovascular, metabolic and liver changes in high carbohydrate, high fat diet-fed rats. Nutrients. 4:1527–1541. 2012. View Article : Google Scholar : PubMed/NCBI

16 

Basso DM, Beattie MS, Bresnahan JC, Anderson DK, Faden AI, Gruner JA, Holford TR, Hsu CY, Noble LJ, Nockels R, et al: MASCIS evaluation of open field locomotor scores: Effects of experience and teamwork on reliability. Multicenter Animal Spinal Cord Injury Study. J Neurotrauma. 13:343–359. 1996. View Article : Google Scholar : PubMed/NCBI

17 

Genovese T, Esposito E, Mazzon E, Muià C, Di Paola R, Meli R, Bramanti P and Cuzzocrea S: Evidence for the role of mitogen-activated protein kinase signaling pathways in the development of spinal cord injury. J Pharmacol Exp Ther. 325:100–114. 2008. View Article : Google Scholar : PubMed/NCBI

18 

Frank J, Chin XW, Schrader C, Eckert GP and Rimbach G: Do tocotrienols have potential as neuroprotective dietary factors? Ageing Res Rev. 11:163–180. 2012. View Article : Google Scholar : PubMed/NCBI

19 

Ahsan H, Ahad A, Iqbal J and Siddiqui WA: Pharmacological potential of tocotrienols: A review. Nutr Metab (Lond). 11:522014. View Article : Google Scholar : PubMed/NCBI

20 

Bao F, Chen Y, Schneider KA and Weaver LC: An integrin inhibiting molecule decreases oxidative damage and improves neurological function after spinal cord injury. Exp Neurol. 214:160–167. 2008. View Article : Google Scholar : PubMed/NCBI

21 

Siddiqui S, Ahsan H, Khan MR and Siddiqui WA: Protective effects of tocotrienols against lipid-induced nephropathy in experimental type-2 diabetic rats by modulation in TGF-β expression. Toxicol Appl Pharmacol. 273:314–324. 2013. View Article : Google Scholar : PubMed/NCBI

22 

Nizar AM, Nazrun AS, Norazlina M, Norliza M and Ima Nirwana S: Low dose of tocotrienols protects osteoblasts against oxidative stress. Clin Ter. 162:533–538. 2011.PubMed/NCBI

23 

Sribnick EA, Wingrave JM, Matzelle DD, Wilford GG, Ray SK and Banik NL: Estrogen attenuated markers of inflammation and decreased lesion volume in acute spinal cord injury in rats. J Neurosci Res. 82:283–293. 2005. View Article : Google Scholar : PubMed/NCBI

24 

Tamai H, Sawamura S, Takeda K, Orii R and Hanaoka K: Anti-allodynic and anti-hyperalgesic effects of nociceptin receptor antagonist, JTC-801, in rats after spinal nerve injury and inflammation. Eur J Pharmacol. 510:223–228. 2005. View Article : Google Scholar : PubMed/NCBI

25 

González AM, Garcia T, Samper E, Rickmann M, Vaquero EC and Molero X: Assessment of the protective effects of oral tocotrienols in arginine chronic-like pancreatitis. Am J Physiol Gastrointest Liver Physiol. 301:G846–G855. 2011. View Article : Google Scholar : PubMed/NCBI

26 

Yam ML, Hafid SR Abdul, Cheng HM and Nesaretnam K: Tocotrienols suppress proinflammatory markers and cyclooxygenase-2 expression in RAW264.7 macrophages. Lipids. 44:787–797. 2009. View Article : Google Scholar : PubMed/NCBI

27 

Chen G, Zhang Z, Wang S and Lv D: Combined treatment with FK506 and nerve growth factor for spinal cord injury in rats. Exp Ther Med. 6:868–872. 2013.PubMed/NCBI

28 

Liu C, Wu W, Zhang B, Xiang J and Zou J: Temporospatial expression and cellular localization of glutamine synthetase following traumatic spinal cord injury in adult rats. Mol Med Rep. 7:1431–1436. 2013.PubMed/NCBI

29 

Qureshi AA, Reis JC, Papasian CJ, Morrison DC and Qureshi N: Tocotrienols inhibit lipopolysaccharide-induced pro-inflammatory cytokines in macrophages of female mice. Lipids Health Dis. 9:1432010. View Article : Google Scholar : PubMed/NCBI

30 

Wang X, Chen W, Liu W, Wu J, Shao Y and Zhang X: The role of thrombospondin-1 and transforming growth factor-beta after spinal cord injury in the rat. J Clin Neurosci. 16:818–821. 2009. View Article : Google Scholar : PubMed/NCBI

31 

Park SM, Jung JS, Jang MS, Kang KS and Kang SK: Transforming growth factor-beta1 regulates the fate of cultured spinal cord-derived neural progenitor cells. Cell Prolif. 41:248–264. 2008. View Article : Google Scholar : PubMed/NCBI

32 

Andrew JG, Hoyland J, Andrew SM, Freemont AJ and Marsh D: Demonstration of TGF-beta 1 mRNA by in situ hybridization in normal human fracture healing. Calcif Tissue Int. 52:74–78. 1993. View Article : Google Scholar : PubMed/NCBI

33 

Gensel JC and Zhang B: Macrophage activation and its role in repair and pathology after spinal cord injury. Brain Res. 1619:1–11. 2015. View Article : Google Scholar : PubMed/NCBI

34 

Kandasamy M, Lehner B, Kraus S, Sander PR, Marschallinger J, Rivera FJ, Trümbach D, Ueberham U, Reitsamer HA, Strauss O, et al: TGF-beta signalling in the adult neurogenic niche promotes stem cell quiescence as well as generation of new neurons. J Cell Mol Med. 18:1444–1459. 2014. View Article : Google Scholar : PubMed/NCBI

35 

Bachman H, Nicosia J, Dysart M and Barker TH: Utilizing fibronectin integrin-binding specificity to control cellular responses. Adv Wound Care (New Rochelle). 4:501–511. 2015. View Article : Google Scholar : PubMed/NCBI

36 

Zhu Y, Soderblom C, Trojanowsky M, Lee DH and Lee JK: Fibronectin matrix assembly after spinal cord injury. J Neurotrauma. 32:1158–1167. 2015. View Article : Google Scholar : PubMed/NCBI

37 

Xia M and Zhu Y: Fibronectin enhances spinal cord astrocyte proliferation by elevating P2Y1 receptor expression. J Neurosci Res. 92:1078–1090. 2014. View Article : Google Scholar : PubMed/NCBI

38 

King VR, Hewazy D, Alovskaya A, Phillips JB, Brown RA and Priestley JV: The neuroprotective effects of fibronectin mats and fibronectin peptides following spinal cord injury in the rat. Neuroscience. 168:523–530. 2010. View Article : Google Scholar : PubMed/NCBI

39 

Xia M: Fibronectin blocks the recovery of spinal cord injury by increasing P2Y1 receptor level. Int J Dev Neurosci. 47:20–21. 2015. View Article : Google Scholar

40 

Koopmans G, Hasse B and Sinis N: Chapter 19: The role of collagen in peripheral nerve repair. Int Rev Neurobiol. 87:363–379. 2009. View Article : Google Scholar : PubMed/NCBI

41 

Liesi P and Kauppila T: Induction of type IV collagen and other basement-membrane-associated proteins after spinal cord injury of the adult rat may participate in formation of the glial scar. Exp Neurol. 173:31–45. 2002. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

July 2017
Volume 14 Issue 1

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Xun, C., Mamat, M., Guo, H., Mamati, P., Sheng, J., Zhang, J. ... Sheng, W. (2017). Tocotrienol alleviates inflammation and oxidative stress in a rat model of spinal cord injury via suppression of transforming growth factor-β. Experimental and Therapeutic Medicine, 14, 431-438. https://doi.org/10.3892/etm.2017.4505
MLA
Xun, C., Mamat, M., Guo, H., Mamati, P., Sheng, J., Zhang, J., Xu, T., Liang, W., Cao, R., Sheng, W."Tocotrienol alleviates inflammation and oxidative stress in a rat model of spinal cord injury via suppression of transforming growth factor-β". Experimental and Therapeutic Medicine 14.1 (2017): 431-438.
Chicago
Xun, C., Mamat, M., Guo, H., Mamati, P., Sheng, J., Zhang, J., Xu, T., Liang, W., Cao, R., Sheng, W."Tocotrienol alleviates inflammation and oxidative stress in a rat model of spinal cord injury via suppression of transforming growth factor-β". Experimental and Therapeutic Medicine 14, no. 1 (2017): 431-438. https://doi.org/10.3892/etm.2017.4505